You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
国药控股(01099.HK)拟18.6亿元收购成大方圆医药100%股权
格隆汇 07-24 19:01

格隆汇7月24日丨国药控股(01099.HK)公布,于2020年7月24日,公司间接附属公司国药控股国大药房有限公司与辽宁成大股份有限公司签署产权交易合同,以代价人民币18.6亿元收购辽宁成大持有的成大方圆医药集团有限公司100%股权。收购事项通过公开摘牌受让方式进行。待收购事项完成后,成大方圆将成为国大药房的全资附属公司,从而成为公司的间接全资附属公司。

成大方圆是汇集医药零售连锁和物流配送于一体的区域性大型医药流通企业,截至2019年末共拥有门店1,507家遍布5省19市,覆盖辽宁、吉林、内蒙古、山东和河北部分重点城市,区域市场集中度优势明显。于2020年3月31日,成大方圆未经审计资产总额约为人民币16.72亿元,归属于母公司所有者权益约为人民币6.04亿元;截至2019年12月31日止年度,成大方圆经审计营业收入约为人民币29.37亿元。于评估基准日2019年6月30日,以市场法评估的成大方圆股东全部权益价值为人民币18.6亿元。

成大方圆零售业务和所在区域符合国大药房“成为中国领先、最受信赖的药店和医药保健零售商”的战略定位,本次收购将有助于国大药房巩固在医药零售领域全国销售规模头部企业地位,进一步提升其市场占有率及集中度,巩固优势区域特别是辽宁区域的领先地位,同时有助于国大药房在医药分开政策背景下提前进行战略布局,为承接处方外流等政策红利做好准备。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account